4DMedical Announces Change of Registry Address in Sydney

An update from 4DMedical Ltd ( (AU:4DX) ) is now available.

4DMedical Limited has announced a change in the address of its registry office in Sydney, effective from April 14, 2025. This move is part of the company’s ongoing efforts to streamline its operations and maintain compliance with ASX regulations. The change is not expected to impact the company’s operations or its stakeholders significantly, as contact details remain unchanged.

More about 4DMedical Ltd

4DMedical Limited is a global medical technology company specializing in respiratory care. The company leverages advanced imaging and AI-powered solutions to provide insights into lung function, facilitating earlier and more precise diagnoses of respiratory diseases. Its patented XV Technology® and FDA-cleared software enable physicians to detect and monitor airflow abnormalities, integrating seamlessly into hospital systems through a SaaS model. The acquisition of Imbio in December 2023 further enhanced its capabilities in AI-driven diagnostics for lung and cardiothoracic diseases.

YTD Price Performance: -46.88%

Average Trading Volume: 995,622

Technical Sentiment Signal: Buy

Current Market Cap: A$114.9M

Find detailed analytics on 4DX stock on TipRanks’ Stock Analysis page.